Drug Discovery and Development Analysis & Statistics, January 2013 (p35)

24/7 Customer Support

Talk to Clare

+1 339 368 6001

All regions

You might be interested in: Clinical Trial, Drug Discovery, Drug Development, more »

1021-1060 of about 2 900 reports

Purchase Reports From Reputable Market Research Publishers

Cytochrome P450 19A1 (CYP19A1) Inhibitors -Pipeline Insights, 2014

Cytochrome P450 19A1 (CYP19A1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cytochrome P450 19A1 (CYP19A1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Cytochrome P450 3A4 (CYP3A4) Inhibitors -Pipeline Insights, 2014

Cytochrome P450 3A4 (CYP3A4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cytochrome P450 3A4 (CYP3A4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Cytochrome P450 Superfamily (CYP or CYP450) Inhibitors -Pipeline Insights, 2014

Cytochrome P450 Superfamily (CYP or CYP450) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cytochrome P450 Superfamily (CYP or CYP450) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
D1 Agonists -Pipeline Insights, 2014

D1 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D1 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to ...

  • Industries : Drug Discovery and Development
D1 Antagonists -Pipeline Insights, 2014

D1 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D1 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
D2 Agonists -Pipeline Insights, 2014

D2 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D2 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to ...

  • Industries : Drug Discovery and Development
D3 Agonists -Pipeline Insights, 2014

D3 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D3 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to ...

  • Industries : Drug Discovery and Development
D3 Antagonists -Pipeline Insights, 2014

D3 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D3 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
D4 Agonists -Pipeline Insights, 2014

D4 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D4 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to ...

  • Industries : Drug Discovery and Development
D4 Antagonists -Pipeline Insights, 2014

D4 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“D4 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Delta Antagonists -Pipeline Insights, 2014

Delta Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Delta Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Diglyceride Acyltransferase (DGAT) Inhibitors -Pipeline Insights, 2014

Diglyceride Acyltransferase (DGAT) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Diglyceride Acyltransferase (DGAT) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Dihydroorotate Dehydrogenase (DHODH) Inhibitors -Pipeline Insights, 2014

Dihydroorotate Dehydrogenase (DHODH) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dihydroorotate Dehydrogenase (DHODH) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Dihydropteroate Synthetase (DHPS) Inhibitors -Pipeline Insights, 2014

Dihydropteroate Synthetase (DHPS) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dihydropteroate Synthetase (DHPS) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Dihydropyrimidine Dehydrogenase (DPD) Inhibitors -Pipeline Insights, 2014

Dihydropyrimidine Dehydrogenase (DPD) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dihydropyrimidine Dehydrogenase (DPD) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
DNA Methyltransferase Inhibitors -Pipeline Insights, 2014

DNA Methyltransferase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA Methyltransferase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
DNA Minor Groove Binders -Pipeline Insights, 2014

DNA Minor Groove Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA Minor Groove Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
DNA Primase Inhibitors -Pipeline Insights, 2014

DNA Primase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA Primase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Dopaminergic Agonists -Pipeline Insights, 2014

Dopaminergic Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dopaminergic Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Dopaminergic system Agonists -Pipeline Insights, 2014

Dopaminergic system Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dopaminergic system Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Dopaminergic system Antagonists -Pipeline Insights, 2014

Dopaminergic system Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dopaminergic system Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
DP1 Receptor (Prostaglandin D2 receptor) Antagonists -Pipeline Insights, 2014

DP1 Receptor (Prostaglandin D2 receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DP1 Receptor (Prostaglandin D2 receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (Dyrk1a) Inhibitors -Pipeline Insights, 2014

Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (Dyrk1a) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (Dyrk1a) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Eg5 Inhibitors -Pipeline Insights, 2014

Eg5 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Eg5 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Elastase Inhibitors -Pipeline Insights, 2014

Elastase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Elastase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Endothelin Receptor (ET) Antagonists -Pipeline Insights, 2014

Endothelin Receptor (ET) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Receptor (ET) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Entry Inhibitors -Pipeline Insights, 2014

Entry Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Entry Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Ephrin (EPH) Receptor Antagonists -Pipeline Insights, 2014

Ephrin (EPH) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ephrin (EPH) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonists -Pipeline Insights, 2014

Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 (EGFL7) Inhibitors -Pipeline Insights, 2014

Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 (EGFL7) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Epidermal Growth Factor (EGF)-Like-Domain, Multiple 7 (EGFL7) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development

86 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.